Business Description
Larimar Therapeutics is a Pennsylvania-based biotech company working to bring new medicines to people with rare and life-threatening conditions. The company has developed a unique technology that allows treatment compounds to enter cells more effectively. Its most advanced drug candidate, CTI-1601, is currently being tested in a Phase 2 clinical trial for Friedreich's ataxia, a rare and progressive disease with no approved cure.
